These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Incidence and Distinct Features of Immune Checkpoint Inhibitor-Related Myositis From Idiopathic Inflammatory Myositis: A Single-Center Experience With Systematic Literature Review and Meta-Analysis. Hamada N; Maeda A; Takase-Minegishi K; Kirino Y; Sugiyama Y; Namkoong H; Horita N; Yoshimi R; Nakajima H; Front Immunol; 2021; 12():803410. PubMed ID: 34938300 [TBL] [Abstract][Full Text] [Related]
4. Characterization of Immune Checkpoint Inhibitor-Induced Myasthenia Gravis Using the US Food and Drug Administration Adverse Event Reporting System. Niimura T; Zamami Y; Miyata K; Mikami T; Asada M; Fukushima K; Yoshino M; Mitsuboshi S; Okada N; Hamano H; Sakurada T; Matsuoka-Ando R; Aizawa F; Yagi K; Goda M; Chuma M; Koyama T; Izawa-Ishizawa Y; Yanagawa H; Fujino H; Yamanishi Y; Ishizawa K J Clin Pharmacol; 2023 Apr; 63(4):473-479. PubMed ID: 36453166 [TBL] [Abstract][Full Text] [Related]
5. [Clinical features of immune checkpoint inhibitor-related myositis in patients with urological cancer]. Ying YC; Tang Q; Yang KW; Mi Y; Fan Y; Yu W; Song Y; He ZS; Zhou LQ; Li XS Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):644-651. PubMed ID: 35950386 [TBL] [Abstract][Full Text] [Related]
6. Improved outcomes with early immunosuppression in patients with immune-checkpoint inhibitor induced myasthenia gravis, myocarditis and myositis: a case series. Weaver JM; Dodd K; Knight T; Chaudhri M; Khera R; Lilleker JB; Roberts M; Lorigan P; Cooksley T Support Care Cancer; 2023 Aug; 31(9):518. PubMed ID: 37572133 [TBL] [Abstract][Full Text] [Related]
7. A case report and literature review on respiratory failure with immune checkpoint inhibitors: a life-threatening adverse event. Lin X; Guan W; Li B; Deng H; Chen Y; Yang Y; Qiu G; Xie X; Zhou C Immunopharmacol Immunotoxicol; 2023 Dec; 45(6):780-787. PubMed ID: 37339370 [TBL] [Abstract][Full Text] [Related]
14. Liver Cancer with Overlapping Myasthenia Gravis, Myocarditis, Seronegative Autoimmune Autonomic Ganglionopathy, and Myositis Symptoms Induced by Atezolizumab. Shibuya R; Baba K; Furuta R; Maesaka H; Hirosawa H; Bando T; Oshima A; Onoda H; Nukui T; Dougu N; Joho S; Nakatsuji Y Intern Med; 2024 Aug; 63(15):2193-2198. PubMed ID: 38171860 [TBL] [Abstract][Full Text] [Related]
15. Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature. Boutros A; Bottini A; Rossi G; Tanda ET; Spagnolo F; Barletta G; Croce E; Fava P; Parisi A; De Rosa F; Palla M; Marconcini R; Ferrari M; Grandis M; Spallarossa P; Sarocchi M; Arboscello E; Del Mastro L; Lambertini M; Pronzato P; Genova C ESMO Open; 2023 Feb; 8(1):100791. PubMed ID: 36791639 [TBL] [Abstract][Full Text] [Related]
16. Immune Checkpoint Inhibitor-Associated Myositis: A Distinct Form of Inflammatory Myopathy. Saygin D; Ghosh N; Reid P J Clin Rheumatol; 2022 Oct; 28(7):367-373. PubMed ID: 35696731 [TBL] [Abstract][Full Text] [Related]
17. Immune checkpoint inhibitor-induced myocarditis, myositis, myasthenia gravis and transaminitis: a case series and review. Wai Siu DH; O'Neill RS; Harris CA; Wang J; Ardolino L; Downton T; Tong M; Hong JH; Chin V; Clingan PR; Aghmesheh M; Soudy H Immunotherapy; 2022 May; 14(7):511-520. PubMed ID: 35321560 [TBL] [Abstract][Full Text] [Related]
18. A Fatal Case of Immune Checkpoint Inhibitor-Mediated Myasthenia Gravis, Myositis, and Cardiomyopathy Overlap Syndrome in Urothelial Carcinoma. Newman MT; Bikhchandani M Cancer Rep (Hoboken); 2024 Jul; 7(7):e2140. PubMed ID: 39041627 [TBL] [Abstract][Full Text] [Related]
19. Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis. Cautela J; Zeriouh S; Gaubert M; Bonello L; Laine M; Peyrol M; Paganelli F; Lalevee N; Barlesi F; Thuny F J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33298621 [TBL] [Abstract][Full Text] [Related]